Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Replimune Group, Inc. (“Replimune” or the ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming October 5, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who ...

We independently review everything we recommend. We may make money from the links on our site. Learn more› By Doug Mahoney Doug Mahoney is a writer covering home-improvement topics, outdoor power ...

A string trimmer is an invaluable piece of your lawn care tool box. Whether you’re tidying up the edges along sidewalks, freshening in and around flowerbeds, or adding a crisp edge to your driveway, ...

Route Z near Gordonville will close Aug. 24 through Sept. 1 for replacement of the Hubble Creek bridge, MoDOT says. Route Z in Cape Girardeau County, from West Clark Street to County Road 222 near ...

Residents of the Great Lakes State can expect mild summers, cold, snowy winters and a relatively low cost of living. Here are the 28 Michigan cities ranked in this year's Best Places to Live, from ...

REPL stock surged about 107% at close after an independent panel of experts advised the U.S. Food and Drug Administration in favor of its experimental treatment for advanced melanoma last week. SNOW ...

・Iovance Biotherapeutics reported strong Q2 results, with revenue reaching $99.3 million on rising Amtagvi demand. ・FDA granted Replimune accelerated approval for TUDRIQEV (RP1) combined with ...